Transcatheter Closure of Ventricular Septal Defect: an Early Experience

  • Dr Mulyadi Djer, University of Indonesia, Jakarta, Indonesia
  • Dr Sukman Putra, University of Indonesia, Jakarta, Indonesia
  • Dr Hasri Samion, Institut Jantung Negara, Kuala Lumpur, Malaysia
  • Background Percutaneous transcatheter closure ventricular septal defect (VSD) is recently more popular because of shorter hospitalization, eliminated the need for thoracotomy, and better cosmetic results without scar..
    Objective To evaluate the efficacy and safety of transcatheter closure of VSD
    Methods A case series of patients who underwent transcatheter closure of VSD at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
    Results In our division since February 2002, transcatheter closure of VSD has been done in 14 patients. The VSD consisted of 12 perimembranous VSD that was closed using membranous VSD occluder and the remaining 2 was muscular VSD that was closed using Amplatzer muscular VSD occluder and Amplatzer septal occluder, respectively. Nine of patients were females and 5 males. The age ranged from 3 to 26 years (median 8 years) and the median of body weight was 23.5 (range 14-68) kg. All patients were discharged at following day after procedure. Patients were followed-up periodically by clinical and echocardiography to monitor the presence of residual shunt or complication. During procedure and follow-up there was no significant complication occurred and no patient had complete AV block.
    Conclusion Based on our experience we conclude that percutaneous transcatheter closure of VSD is effective and save.

    Keyword: Ventricular septal defect, Amplatzer occluder.